American Portfolios Advisors’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$196 Hold
6
﹤0.01% 3459
2022
Q2
$215 Hold
6
﹤0.01% 3462
2022
Q1
$701 Hold
6
﹤0.01% 3426
2021
Q4
$593 Hold
6
﹤0.01% 3395
2021
Q3
$549 Hold
6
﹤0.01% 3378
2021
Q2
$760 Hold
6
﹤0.01% 3290
2021
Q1
$988 Buy
+6
New +$1.02K ﹤0.01% 3137
2020
Q4
Sell
-50
Closed -$9.29K 3040
2020
Q3
$9.29K Buy
+50
New +$8.19K ﹤0.01% 2011

Other funds holding IMUX

American Portfolios Advisors's IMUX Position: Q3 2022 in Review

American Portfolios Advisors held its Immunic (IMUX) position steady in Q3 2022 at 6 shares worth $196. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

American Portfolios Advisors first reported a position in IMUX in Q3 2020 and has held it in 8 quarters since. The position peaked at $9.29K in Q3 2020. 65 funds tracked by Wall St. Rank hold IMUX as of Q3 2022.

  • American Portfolios Advisors held 6 shares of Immunic worth $196 as of Q3 2022.
  • American Portfolios Advisors left its Immunic share count unchanged in Q3 2022.
  • Immunic made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3459 holding.
  • American Portfolios Advisors first reported a position in Immunic in Q3 2020 and has held it in 8 quarters since.
  • American Portfolios Advisors's Immunic position peaked at $9.29K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.